CRMD Chart
- 52-Week Range: $2.98 - $8.25
- Market Capitalization: $131.45M
- Short Percentage: 0%
- Target Price: $22.00
- Shares Outstanding: 38.73M
- Next Earnings: Nov 30
Catalysts
CategoryCatalyst
Earnings
CRMD released their earnings report for the previous quarter and provided guidance on the current and upcoming quarters.
News and Press Releases
- CorMedix Inc. (CRMD) CEO Joe Todisco on Q1 2022 Results - Earnings Call TranscriptSeeking Alpha | May 12th
- CorMedix Inc. to Present at the 21st Annual Needham Virtual Healthcare ConferenceGlobeNewsWire | April 4th
- CorMedix Inc. (CRMD) CEO Matt David on Q4 2021 Results - Earnings Call TranscriptSeeking Alpha | March 29th
- Cormedix Inc. Announces Resubmission of New Drug Application for DefenCathGlobeNewsWire | February 28th
- CorMedix Inc. (CRMD) CEO Matt David on Q3 2021 Earnings Call TranscriptSeeking Alpha | November 9th
- CorMedix Inc. to Report Third Quarter 2021 Financial Results and Provide a Corporate Update on November 9GlobeNewsWire | November 2nd
Company Info
Website: https://www.cormedix.com
Address: 300 Connell Drive, Berkeley Heights, NJ, United States, 07922
Sector: Healthcare
Industry: Biotechnology
Full time employees: 29
Address: 300 Connell Drive, Berkeley Heights, NJ, United States, 07922
Sector: Healthcare
Industry: Biotechnology
Full time employees: 29
$CRMD Lol she wants higher
$CRMD is it time?
$CRMD buying this dip
$CRMD Buy the dip
$CRMD holding unfortunately lol
$CRMD market starting to dump
$CRMD call the SEC
$CRMD Many many bears
$CRMD I warned everyone this company sucks
$CRMD bears go away.